Literature DB >> 25515540

Urinary creatinine adjustment for uranium and kidney outcomes from lead workers.

Tomoyuki Kawada1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25515540     DOI: 10.1038/jes.2014.77

Source DB:  PubMed          Journal:  J Expo Sci Environ Epidemiol        ISSN: 1559-0631            Impact factor:   5.563


× No keyword cloud information.
  6 in total

1.  Variability of urinary cadmium excretion in spot urine samples, first morning voids, and 24 h urine in a healthy non-smoking population: implications for study design.

Authors:  Magnus Akerstrom; Lars Barregard; Thomas Lundh; Gerd Sallsten
Journal:  J Expo Sci Environ Epidemiol       Date:  2013-09-11       Impact factor: 5.563

2.  Effects of cadmium and lead exposure on urinary N-acetyl-beta-D-glucosaminidase, beta 2-microglobulin and metallothionein of workers.

Authors:  T Kawada; C Tohyama; S Suzuki
Journal:  Asia Pac J Public Health       Date:  1995       Impact factor: 1.399

3.  Estimated glomerular filtration rate by two equations and their relationship with metabolic syndrome.

Authors:  Tomoyuki Kawada
Journal:  Clin Chim Acta       Date:  2014-04-29       Impact factor: 3.786

4.  Validating GFR estimating samples with clinical outcomes.

Authors:  Tomoyuki Kawada
Journal:  Am J Kidney Dis       Date:  2014-05       Impact factor: 8.860

5.  [Concentration correction and standardization of some constituents in spot urine by using creatinine concentration in urine].

Authors:  T Kawada; S Suzuki; H Koyama
Journal:  Sangyo Igaku       Date:  1987-09

6.  Uranium associations with kidney outcomes vary by urine concentration adjustment method.

Authors:  Rebecca Shelley; Nam-Soo Kim; Patrick J Parsons; Byung-Kook Lee; Jacqueline Agnew; Bernard G Jaar; Amy J Steuerwald; Genevieve Matanoski; Jeffrey Fadrowski; Brian S Schwartz; Andrew C Todd; David Simon; Virginia M Weaver
Journal:  J Expo Sci Environ Epidemiol       Date:  2013-04-17       Impact factor: 5.563

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.